We tested the ability of Prostate Imaging Reporting and Data System (PI-RADS) score and prostate-specific antigen density (PSAD) in predicting the risk of reclassification during active surveillance. Three hundred eighty-nine patients underwent multiparametric magnetic resonance imaging and subsequent confirmatory or follow-up biopsy. PSAD ≥ 0.20 ng/mL2 may improve predictive accuracy of multiparametric magnetic resonance imaging results for reclassification of patients in active surveillance, whereas PSAD < 0.10 ng/mL2 may help selection of patients at lower risk of harboring clinically significant prostate cancer.

Roscigno, M., Stabile, A., Lughezzani, G., Pepe, P., Galosi, A., Naselli, A., et al. (2020). The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?. CLINICAL GENITOURINARY CANCER, 18(6), 698-704 [10.1016/j.clgc.2020.04.006].

The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?

Roscigno M.
;
Sironi S.;Da Pozzo L. F.
2020

Abstract

We tested the ability of Prostate Imaging Reporting and Data System (PI-RADS) score and prostate-specific antigen density (PSAD) in predicting the risk of reclassification during active surveillance. Three hundred eighty-nine patients underwent multiparametric magnetic resonance imaging and subsequent confirmatory or follow-up biopsy. PSAD ≥ 0.20 ng/mL2 may improve predictive accuracy of multiparametric magnetic resonance imaging results for reclassification of patients in active surveillance, whereas PSAD < 0.10 ng/mL2 may help selection of patients at lower risk of harboring clinically significant prostate cancer.
Articolo in rivista - Articolo scientifico
Biopsy; MRI-TRUS fusion; Multiparametric MRI; Prostate; Prostate cancer;
English
2020
18
6
698
704
none
Roscigno, M., Stabile, A., Lughezzani, G., Pepe, P., Galosi, A., Naselli, A., et al. (2020). The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?. CLINICAL GENITOURINARY CANCER, 18(6), 698-704 [10.1016/j.clgc.2020.04.006].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/470659
Citazioni
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 25
Social impact